Should You Buy Adamas Pharma Stock Ahead Of Upcoming PDUFA On August 24?
We picked Adamas Pharmaceuticals (ADMS) stock in our portfolio last year (see initiation article with full details). We reiterated Buy on the stock in a premium service post last month. We are revisiting this company ahead of the August 24 PDUFA date for ADS-5102 in the treatment of levodopa-induced dyskinesia, LID in Parkinson's disease, PD.